Wide Ranks

IGC

IGC Pharma, Inc.

0.3740

Top Statistics
Market Cap 28 M Forward PE -3.12 Revenue Growth -51.00 %
Current Ratio 1.77 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.79 Enterprise / Revenue 24.75 Price To Sales Trailing12 Months 27.28
Profitability
Profit Margins 0.00 % Operating Margins -871.32 %
Balance Sheet
Total Cash 1 M Total Cash Per Share 0.0240 Total Debt 338000
Total Debt To Equity 4.29 Current Ratio 1.77 Book Value Per Share 0.1100
All Measures
Short Ratio 229.00 % Message Board Id finmb_22356580 Shares Short Prior Month 1 M
Return On Equity -1.26 City Potomac Uuid dce893e5-9c03-3b1b-b9a2-7af606299cd2
Previous Close 0.3770 First Trade Date Epoch Utc 1 B Book Value 0.1100
Beta 1.29 Total Debt 338000 Volume 105188
Price To Book 3.40 Last Split Date 1 B Fifty Two Week Low 0.2500
Total Cash Per Share 0.0240 Total Revenue 1 M Shares Short Previous Month Date 1 B
Target Median Price 3.62 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -871.32 % Target Mean Price 3.62 Net Income To Common -13303000
Ask 0.3782 Short Percent Of Float 0.0240 Implied Shares Outstanding 77 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 317320
Average Volume10days 317320 Total Cash 1 M Next Fiscal Year End 1 B
Revenue Per Share 0.0170 Held Percent Insiders 0.0792 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.3770
Target Low Price 3.50 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.3742
Open 0.3500 Free Cashflow -3514625 State MD
Dividend Yield 0.00 % Return On Assets -0.4782 Time Zone Short Name EST
Trailing Eps -0.2000 Day Low 0.3500 Address1 10224 Falls Road
Shares Outstanding 77 M Price Hint 4 Target High Price 3.75
Website https://igcpharma.com 52 Week Change 0.1562 Average Volume 395712
Forward Eps -0.1000 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 76.50 % Last Split Factor 1:10 Regular Market Day High 0.3780
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 4.29
Fifty Two Week High 0.9100 Day High 0.3780 Shares Short 1 M
Regular Market Open 0.3500 Industry Key biotechnology Bid 0.3712
Earnings Growth 0.00 % Enterprise To Revenue 24.75 Revenue Growth -51.00 %
Shares Percent Shares Out 0.0162 Operating Cashflow -5483000 Currency USD
Time Zone Full Name America/New_York Market Cap 28 M Is_nasdaq_100 False
Zip 20854 Quote Type EQUITY Industry Biotechnology
Long Name IGC Pharma, Inc. Regular Market Day Low 0.3500 Held Percent Institutions 0.2200
Current Price 0.3740 Enterprise To Ebitda -2.79 Financial Currency USD
Current Ratio 1.77 Gross Margins 60.36 % Industry Disp Biotechnology
Number Of Analyst Opinions 2 Country United States Float Shares 68 M
Two Hundred Day Average 0.4168 Ir Website http://www.indiaglobalcap.com/stockprice.php Enterprise Value 26 M
Price To Sales Trailing12 Months 27.28 Forward PE -3.12 Regular Market Volume 105188
Ebitda -9405000 Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease.

The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development.

The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023.

The company was incorporated in 2005 and is headquartered in Potomac, Maryland.